- Home
- ICL vs QGEN Comparison
ICL vs QGEN Comparison
Compare ICL & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICL
- QGEN
- Stock Information
- Founded
- ICL 1968
- QGEN 1986
- Country
- ICL Israel
- QGEN Netherlands
- Employees
- ICL N/A
- QGEN N/A
- Industry
- ICL Agricultural Chemicals
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ICL Industrials
- QGEN Health Care
- Exchange
- ICL Nasdaq
- QGEN Nasdaq
- Market Cap
- ICL 8.7B
- QGEN 9.1B
- IPO Year
- ICL N/A
- QGEN 1996
- Fundamental
- Price
- ICL $6.76
- QGEN $48.02
- Analyst Decision
- ICL Hold
- QGEN Buy
- Analyst Count
- ICL 2
- QGEN 9
- Target Price
- ICL $6.75
- QGEN $50.79
- AVG Volume (30 Days)
- ICL 789.2K
- QGEN 1.3M
- Earning Date
- ICL 08-13-2025
- QGEN 07-30-2025
- Dividend Yield
- ICL 2.80%
- QGEN 3.15%
- EPS Growth
- ICL N/A
- QGEN N/A
- EPS
- ICL 0.30
- QGEN 0.42
- Revenue
- ICL $6,873,000,000.00
- QGEN $2,002,874,000.00
- Revenue This Year
- ICL $4.71
- QGEN $6.36
- Revenue Next Year
- ICL $4.08
- QGEN $6.18
- P/E Ratio
- ICL $22.39
- QGEN $113.60
- Revenue Growth
- ICL N/A
- QGEN 3.31
- 52 Week Low
- ICL $3.79
- QGEN $37.63
- 52 Week High
- ICL $7.04
- QGEN $48.36
- Technical
- Relative Strength Index (RSI)
- ICL 56.03
- QGEN 71.53
- Support Level
- ICL $6.64
- QGEN $46.37
- Resistance Level
- ICL $6.85
- QGEN $46.83
- Average True Range (ATR)
- ICL 0.12
- QGEN 0.69
- MACD
- ICL 0.01
- QGEN -0.00
- Stochastic Oscillator
- ICL 87.23
- QGEN 89.25
About ICL ICL Group Ltd.
ICL Group Ltd is a manufacturer of products based on minerals. The firm is comprised of four segments: phosphate solutions, potash, industrial products, and growing solutions. These segments all contribute to the company's development of agriculture, food, and engineered material products and services. Maximum revenue is generated from its phosphate solutions segment which uses phosphate commodity products, such as phosphate rock and fertilizer-grade phosphoric acid (green phosphoric acid), to produce specialty products. This segment also produces and markets phosphate-based fertilizers. Geographically, the company generates maximum revenue from Brazil followed by, the United States of America, China, United Kingdom, Germany, Spain, Israel, France, India, Netherlands, and other countries.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).